Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

Molecular and Cellular Biology

Volumn 17, Issue 7, 1997, Pages 4015-4023

  Yoshida, Shigeo ^a   Ono, Mayumi ^a   Shono, Tadahisa ^a   Izumi, Hiroto ^a   Ishibashi, Tatsuro ^a   Suzuki, Hideo ^b   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Base Technology Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; OLIGONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NORTHERN BLOTTING; PRIORITY JOURNAL;

ORYCTOLAGUS CUNICULUS;

EID: 0031009807     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.7.4015     Document Type: Article

References (69)

1. Abe, T., K. Okamura, M. Onu, K. Kohno, T. Mori, S. Hori, and M. Kuwano. 1993. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. J. Clin. Invest. 92:54-61.
2. Asakuno, K., M. Isono, Y. Wakabayashi, T. Mori, S. Hori, K. Kohno, and M. Kuwano. 1995. The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into the rat brain. Brain Res. 702:23-31.
3. BenEzra, D., I. Hemo, and G. Maftzir. 1990. In vivo angiogenic activity of interleukins. Arch. Ophthalmol. 108:573-576.
4. Bussolino, F., G. Camussi, and C. Baglioni. 1988. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J. Biol. Chem. 263:11856-11861.
5. 4a.Chiao, P., W. Wang, L. Ellis, and D. Shen. 1996. NF-ΚB regulates VEGF gene expression in human pancreatic cancers. Am. Assoc. Cancer Res. Proc. 37:525.
6. Clauss, M., M. Gerlach, H. Gerlach, J. Brett, F. Wang, P. C. Familletti, Y. C. Pan, J. V. Olander, D. T. Connolly, and D. Stern. 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172:1535-1545.
7. Defilippi, P., G. Truffa, G. Stefanuto, F. Altruda, L. Silengo, and G. Tareno. 1991. Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. J. Biol. Chem. 266:7638-7645.
8. de Vries, C., J. A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L. T. Williams. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
9. Dionne, C. A., G. Crumley, F. Bellot, J. M. Kaplow, G. Searfoss, M. Ruta, W. H. Burgess, M. Jaye, and J. Schlessinger. 1990. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9:2685-2692.
10. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978.
11. Elner, V. M., R. M. Strieter, M. A. Pavilack, S. G. Elner, D. G. Remick, J. M. Danforth, and S. L. Kunkel. 1991. Human corneal interleukin-8. IL-1 and TNF-induced gene expression and secretion. Am. J. Pathol. 139:977-988.
12. Fajardo, L. F., H. H. Kwan, J. Kowalski, S. D. Prionas, and A. C. Allison. 1992. Dual role of tumor necrosis factor-alpha in angiogenesis. Am. J. Pathol. 140:539-544.
13. Fidler, I. J., and L. M. Ellis. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188.
14. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
15. Folkman, J., and M. Klagsburn. 1987. Angiogenic factors. Science 235:442-447.
16. Frater-Schroder, M., W. Risau, R. Hallmann, P. Gautschi, and P. Bohlen. 1987. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84:5227-5281.
17. Gimbrone, M., Jr., and P. M. Gullino. 1976. Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues. J. Natl. Cancer Inst. 56:305-318.
18. Hamanaka, R., K. Kohno, T. Seguchi, K. Okamura, A. Morimoto, M. Ono, J. Ogata, and M. Kuwano. 1992. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. J. Biol. Chem. 267:13160-13165.
19. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
20. Hayashi, T., T. Sekine, and T. Okamoto. 1993. Identification of a new serine kinase that activates NF kappa B by direct phosphorylation. J. Biol. Chem. 268:26790-26795.
21. Hayashi, T., Y. Ueno, and T. Okamoto. 1993. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:11380-11388.
22. Holmes, W. E., J. Lee, W. J. Kuang, G. C. Rice, and W. I. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253:1278-1280.
23. Ida, N., S. Sakurai, K. Hosoi, and T. Kunitomo. 1992. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. J. Immunul. Methods 156:27-38.
24. Izumi, H., M. Ono, S. Ushiro, K. Kohno, H. F. Kung, and M. Kuwano. 1994. Cross-talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells. Exp. Cell Res. 214:654-662.
25. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophagederived mediator of angiogenesis. Science 258:1798-1801.
26. Kohno, K., R. Hamanaka, T. Abe, Y. Nomura, A. Morimoto, H. Izumi, K. Shimizu, M. Ono, and M. Kuwano. 1993. Morphological change and destabilization of beta-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp. Cell Res. 208:498-503.
27. Kondo, S., M. Asano, and H. Suzuki. 1993. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem. Biophys. Res. Commun. 194:1234-1241.
28. Kronke, M., S. Schutze, P. Scheurich, and K. Pfizenmaier. 1992. TNF signal transduction and TNF-responsive genes. Immunol. Ser. 56:189-216.
29. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:4625-4629.
30. Leibovich, S. J., P. J. Polverini, H. M. Shepard, D. M. Wiseman, V. Shively, and N. Nuseir. 1987. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630-632.
31. Lewis, C. E., R. Leek, A. Harris, and J. O. McGee. 1995. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J. Leukocyte Biol. 57:747-751.
32. Li, Y., G. Mak, and B. Franza, Jr. 1994. In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. J. Biol. Chem. 269:30616-30619.
33. Libby, P., J. M. Ordovas, K. R. Auger, A. H. Robbins, L. K. Birinyi, and C. A. Dinarello. 1986. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124:179-185.
34. Lo, Y. Y., and T. F. Cruz. 1995. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 270:11727-11730.
35. Lowenthal, J. W., D. W. Ballard, E. Bohnlein, and W. C. Greene. 1989. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2331-2335.
36. Matsukura, M., K. Shinozuka, G. Zon, H. Mitsuya, M. Reitz, J. S. Cohen, and S. Broder. 1987. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84:7706-7710.
37. Mawatari, M., K. Kohno, H. Mizoguchi, T. Matsuda, K. Asoh, J. Van Damme, H. G. Welgus, and M. Kuwano. 1989. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J. Immunol. 143:1619-1627.
38. Mawatari, M., K. Okamura, T. Matsuda, R. Hamanaka, H. Mizoguchi, K. Higashio, K. Kohno, and M. Kuwano. 1991. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. Exp. Cell Res. 192:574-580.
39. Millauer, B., S. Wizigmann-Voos, H. Schnurch, R. Martinez, N. P. Moller, W. Risau, and A. Ullrich. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
40. Montrucchio, G., E. Lupia, E. Battaglia, G. Passerini, F. Bussolino, G. Emanuelli, and G. Camussi. 1994. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180:377-382.
41. Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143:1366-1371.
42. Murphy, L. D., C. E. Herzog, J. B. Rudick, A. T. Fojo, and S. E. Bates. 1990. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 29:10351-10356.
43. Murphy, P. M., and H. L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280-1283.
44. Nawroth, P. P., I. Bank, D. Handley, J. Cassimeris, L. Chess, and D. Stern. 1986. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med. 163:1363-1375.
45. Nomura, M., S. Yamagishi, S. Harada, Y. Hayashi, T. Yamashima, J. Yamashita, and H. Yamamoto. 1995. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270:28316-28324.
46. Okamura, K., A. Morimoto, R. Hamanaka, M. Ono, K. Kohno, Y. Uchida, and M. Kuwano. 1992. A model system for tumor angiogenesis: involvement of transforming growth factor-alpha in tube formation of human microvascular endothelial cells induced by esophageal cancer cells. Biochem. Biophys. Res. Commun. 186:1471-1479.
47. Okamura, K., Y. Sato, T. Matsuda, R. Hamanaka, M. Ono, K. Kohno, and M. Kuwano. 1991. Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. J. Biol. Chem. 266:19162-19165.
48. Ono, M., K. Okamura, Y. Nakayama, M. Tomita, Y. Sato, Y. Komatsu, and M. Kuwano. 1992. Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: involvement of transforming growth factor-alpha. Biochem. Biophys. Res. Commun. 189:601-609.
49. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86: 2336-2340.
50. Pandey, A., H. Shao, R. M. Marks, P. J. Polverini, and V. M. Dixit. 1995. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268:567-569.
51. Passaniti, A., R. M. Taylor, R. Pili, Y. Guo, P. V. Long, J. A. Haney, R. R. Pauly, D. S. Grant, and G. R. Martin. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67:519-528.
52. Patterson, C., M. A. Perrella, C. M. Hsieh, M. Yoshizumi, M. E. Lee, and E. Haber. 1995. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem. 270:23111-23118.
53. Perkins, N. D., N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel. 1993. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551-3558.
54. Pober, J. S., M. Gimbrone, Jr., L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
55. Pusztai, L., L. M. Clover, K. Cooper, P. M. Starkey, C. E. Lewis, and J. O. McGee. 1994. Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br. J. Cancer 70:289-292.
56. Ramasamy, S., D. W. Lipke, C. J. McClain, and B. Hennig. 1995. Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J. Cell. Physiol. 162:119-126.
57. Ryuto, M., M. Ono, H. Izumi, S. Yoshida, H. A. Weich, K. Kohno, and M. Kuwano. 1996. Induction of vascular endothelial growth factor by tumor necrosis factor-alpha in human glioma cells: possible roles of Sp-1. J. Biol. Chem. 271:28220-28228.
58. Saffer, J. D., S. P. Jackson, and M. B. Annarella. 1991. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11:2189-2199.
59. Sato, N., K. Fukuda, H. Nariuchi, and N. Sagara. 1987. Tumor necrosis factor inhibiting angiogenesis in vitro. JNCI 79:1383-1391.
60. Sato, Y., K. Okamura, A. Morimoto, R. Hamanaka, K. Hamaguchi, T. Shimada, M. Ono, K. Kohno, T. Sakata, and M. Kuwano. 1993. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp. Cell Res. 204:223-229.
61. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258.
62. Schutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. 1992. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776.
63. Schweigerer, L., B. Malerstein, and D. Gospodarowicz. 1987. Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem. Biophys. Res. Commun. 143:997-1004.
64. Shibata, F., A. Baird, and R. Z. Florkiewicz. 1991. Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 4:277-287.
65. Shono, T., M. Ono, H. Izumi, S. Jimi, K. Matsushima, T. Okamoto, K. Kohno, and M. Kuwano. 1996. Involvement of the transcription factor NF-ΚB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16:4231-4239.
66. Stoltz, R. A., N. G. Abraham, and M. Laniado-Schwartzman. 1996. The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells. Proc. Natl. Acad. Sci. USA 93:2832-2837.
67. Terman, B. I., M. Dougher-Vermazen, M. E. Carrion, D. Dimitrov, D. C. Armellino, D. Gospodarowicz, and P. Bohlen. 1992. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1579-1586.
68. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes, and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:11947-11954.
69. Wakabayashi, Y., T. Shono, M. Isono, S. Hori, K. Matsushima, M. Ono, and M. Kuwano. 1995. Dual pathways to tubular morphogenesis of vascular endothelial cells by human glioma cells: vascular endothelial growth factor/ basic fibroblast growth factor and interleukin-8. Jpn. J. Cancer Res. 86:1189-1197.